156 related articles for article (PubMed ID: 29170518)
1. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".
Watt JM; Graeff R; Thomas MP; Potter BVL
Sci Rep; 2017 Nov; 7(1):16100. PubMed ID: 29170518
[TBL] [Abstract][Full Text] [Related]
2. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.
Moreau C; Liu Q; Graeff R; Wagner GK; Thomas MP; Swarbrick JM; Shuto S; Lee HC; Hao Q; Potter BV
PLoS One; 2013; 8(6):e66247. PubMed ID: 23840430
[TBL] [Abstract][Full Text] [Related]
3. Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.
Kirchberger T; Wagner G; Xu J; Cordiglieri C; Wang P; Gasser A; Fliegert R; Bruhn S; Flügel A; Lund FE; Zhang LH; Potter BV; Guse AH
Br J Pharmacol; 2006 Oct; 149(4):337-44. PubMed ID: 16967053
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
Swarbrick JM; Graeff R; Zhang H; Thomas MP; Hao Q; Potter BV
J Med Chem; 2014 Oct; 57(20):8517-29. PubMed ID: 25226087
[TBL] [Abstract][Full Text] [Related]
5. Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-
Watt JM; Graeff R; Potter BVL
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885748
[TBL] [Abstract][Full Text] [Related]
6. Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.
Watt JM; Thomas MP; Potter BVL
Sci Rep; 2018 Oct; 8(1):15268. PubMed ID: 30323284
[TBL] [Abstract][Full Text] [Related]
7. Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog.
Liu Q; Kriksunov IA; Moreau C; Graeff R; Potter BV; Lee HC; Hao Q
J Biol Chem; 2007 Aug; 282(34):24825-32. PubMed ID: 17591784
[TBL] [Abstract][Full Text] [Related]
8. 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist.
Kirchberger T; Moreau C; Wagner GK; Fliegert R; Siebrands CC; Nebel M; Schmid F; Harneit A; Odoardi F; Flügel A; Potter BV; Guse AH
Biochem J; 2009 Jul; 422(1):139-49. PubMed ID: 19492987
[TBL] [Abstract][Full Text] [Related]
9. Rapid synthetic route toward structurally modified derivatives of cyclic adenosine 5'-diphosphate ribose.
Wagner GK; Guse AH; Potter BV
J Org Chem; 2005 Jun; 70(12):4810-9. PubMed ID: 15932322
[TBL] [Abstract][Full Text] [Related]
10. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.
Graeff R; Liu Q; Kriksunov IA; Kotaka M; Oppenheimer N; Hao Q; Lee HC
J Biol Chem; 2009 Oct; 284(40):27629-36. PubMed ID: 19640843
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist.
Swarbrick JM; Potter BV
J Org Chem; 2012 May; 77(9):4191-7. PubMed ID: 22283398
[TBL] [Abstract][Full Text] [Related]
13. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a new N-9 ribityl analogue of cyclic inosine diphosphate ribose (cIDPR) as a mimic of cyclic ADP ribose (cADPR).
Oliviero G; Amato J; Varra M; Piccialli G; Mayol L
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):735-8. PubMed ID: 16248026
[TBL] [Abstract][Full Text] [Related]
15. Cluster of differentiation 38 (CD38) mediates bile acid-induced acinar cell injury and pancreatitis through cyclic ADP-ribose and intracellular calcium release.
Orabi AI; Muili KA; Javed TA; Jin S; Jayaraman T; Lund FE; Husain SZ
J Biol Chem; 2013 Sep; 288(38):27128-27137. PubMed ID: 23940051
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38.
Liu Q; Kriksunov IA; Graeff R; Lee HC; Hao Q
J Biol Chem; 2007 Feb; 282(8):5853-61. PubMed ID: 17182614
[TBL] [Abstract][Full Text] [Related]
17. Blocking the CD38/cADPR pathway plays a double-edged role in LPS stimulated microglia.
Wang YM; Liu ZY; Ai YH; Zhang LN; Zou Y; Peng QY
Neuroscience; 2017 Oct; 361():34-42. PubMed ID: 28807785
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CD38/Cyclic ADP-ribose Pathway Protects Rats against Ropivacaine-induced Convulsion.
Zou Y; He X; Peng QY; Guo QL
Chin Med J (Engl); 2017 Oct; 130(19):2354-2360. PubMed ID: 28937043
[TBL] [Abstract][Full Text] [Related]
19. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia.
Banerjee S; Walseth TF; Borgmann K; Wu L; Bidasee KR; Kannan MS; Ghorpade A
J Neuroimmune Pharmacol; 2008 Sep; 3(3):154-64. PubMed ID: 18581239
[TBL] [Abstract][Full Text] [Related]
20. Measuring CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) activity by reverse-phase HPLC.
Kirchberger T; Guse AH
Cold Spring Harb Protoc; 2013 Jun; 2013(6):569-73. PubMed ID: 23734017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
